Breaking News, Collaborations & Alliances

RainDance Technologies, Ambry Genetics Enter ADME Pact

RainDance Technologies, Inc. and Ambry Genetics have entered a collaboration focused on the development and commercialization of a comprehensive drug absorption, distribution, metabolism, and excretion (ADME) genetic screening panel.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

RainDance Technologies, Inc. and Ambry Genetics have entered a collaboration focused on the development and commercialization of a comprehensive drug absorption, distribution, metabolism, and excretion (ADME) genetic screening panel for use on next-generation sequencing (NGS) systems. Financial terms were not disclosed. The new ADME panel leverages RainDance’s primer design methods and microdroplet-based RDT 1000 platform. It’s designed to provide scientists with the capacity to perform...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters